Procalcitonin levels in septic and nonseptic subjects with AKI and ESKD prior to and during continuous kidney replacement therapy (CKRT)

Background Procalcitonin is a 14.5 kDa protein used clinically as a marker of sepsis and therapeutic response to antibiotic therapy. However, its utility in critically ill patients with either acute kidney injury (AKI) or end-stage kidney disease (ESKD) who require continuous kidney replacement ther...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Critical care (London, England) Ročník 29; číslo 1; s. 171
Hlavní autori:	Foulon, North, Haeger, Sarah M., Okamura, Kayo, He, Zhibin, Park, Bryan D., Budnick, Isadore M., Madison, David, Kennis, Matthew, Blaine, Rachel, Miyazaki, Makoto, Jalal, Diana I., Griffin, Benjamin R., Aftab, Muhammad, Colbert, James F., Faubel, Sarah
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 30.04.2025 BioMed Central Ltd Springer Nature B.V
Predmet:	Acute Kidney Injury - blood Acute Kidney Injury - therapy Aged Analysis Antibiotics Bacterial infections Biomarkers - analysis Biomarkers - blood Blood proteins Care and treatment Chronic kidney failure Cohort Studies Complications and side effects Continuous Renal Replacement Therapy - methods Creatinine Critical Care Medicine Critically ill Diagnosis Electronic health records Emergency Medicine Female Health aspects Hemodialysis Hemodynamics Humans Infection Intensive Kidney diseases Kidney Failure, Chronic - blood Kidney Failure, Chronic - therapy Male Medicine Medicine & Public Health Middle Aged Performance evaluation Plasma Population Procalcitonin - analysis Procalcitonin - blood Renal replacement therapy Retrospective Studies Risk factors Sepsis Sepsis - blood Sepsis - diagnosis United States Sepsis CKRT Procalcitonin ESKD AKI
ISSN:	1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!